5/5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg BPC-157 + 2,500 mcg TB-500 per mL 250 mcg dose (of each) = 10 units (0.1 mL) on a 100-unit insulin syringe 500 mcg dose (of each) = 20 units (0.2 mL) on a 100-unit insulin syringe Doses per vial: 20 doses at 250 mcg each, or 10 doses at 500 mcg each Supplies Needed (4-Week Loading at 500 mcg/day) 3 vials BPC-157/TB-500 blend (5/5 mg each) provides 30 doses at 500 mcg, covers 28 days with margin 3 vials bacteriostatic water (30 mL each) 30 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique Standard subcutaneous injection
Three mechanistic explanations, not mutually exclusive: Signalling cascade persistence: BPC-157 activates VEGFR2 and FAK-paxillin pathways whose downstream effects (angiogenesis, fibroblast migration, collagen remodelling) unfold over days to weeks after initial receptor engagement
Box of 10 ampoules (5ml each 50ml total)
The Pure Glow Fusion is a longevity + recovery-focused peptide blend designed to support the things people usually care about most: healthier-looking skin, faster recovery, and better overall resilience
Mild Side Effects These side effects are reported anecdotally and tend to resolve on their own within a few days of use or dose adjustment: Headache or light-headedness Mild nausea or upset stomach (especially with oral use) Fatigue or lethargy in the first few days of use Appetite changes (increase or decrease) Injection site irritation redness, swelling, or tenderness Mild dizziness, nausea, and local irritation are among the most commonly reported side effects of subcutaneous BPC-157 injection, typically resolving within 2472 hours. Milekic, T